Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced CardiotoxicityIn VitroandIn Vivo

Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells

(2011) Jingwei Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer

(2011) Jessica M. Scott et al.   CIRCULATION

Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders

(2011) Morris Karmazyn et al.   DRUGS

Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo

(2011) Sankarganesh Arunachalam et al.   Journal of Natural Medicines

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

(2011) Jing Xiao et al.   TOXICOLOGY

Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt

(2010) E-K Park et al.   BRITISH JOURNAL OF PHARMACOLOGY

Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53

(2010) Binghui Li et al.   CANCER LETTERS

Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both

(2010) David Schibilsky et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis

(2009) Dan Zhu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes

(2009) Rong Shi et al.   BMC Pharmacology & Toxicology

Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo

(2008) Hongbo Wang et al.   CANCER LETTERS

Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway

(2008) Wuqiang Zhu et al.   CIRCULATION